Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$11.38 - $19.03 $67,938 - $113,609
5,970 New
5,970 $109,000
Q3 2023

Oct 13, 2023

BUY
$14.99 - $32.65 $143,799 - $313,211
9,593 New
9,593 $144,000
Q1 2023

Apr 28, 2023

BUY
$38.09 - $57.79 $472,239 - $716,480
12,398 Added 165.28%
19,899 $779,000
Q4 2022

Feb 02, 2023

SELL
$40.54 - $56.2 $337,049 - $467,246
-8,314 Reduced 52.57%
7,501 $396,000
Q3 2022

Oct 31, 2022

BUY
$36.98 - $49.2 $179,648 - $239,013
4,858 Added 44.34%
15,815 $712,000
Q2 2022

Jul 29, 2022

BUY
$28.03 - $45.8 $307,124 - $501,830
10,957 New
10,957 $399,000
Q1 2022

Apr 29, 2022

SELL
$29.24 - $44.06 $723,894 - $1.09 Million
-24,757 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$39.32 - $61.61 $158,184 - $247,857
4,023 Added 19.4%
24,757 $1.06 Million
Q3 2021

Nov 01, 2021

BUY
$44.0 - $65.8 $658,372 - $984,565
14,963 Added 259.28%
20,734 $1.14 Million
Q2 2021

Aug 12, 2021

SELL
$44.66 - $63.06 $34,566 - $48,808
-774 Reduced 11.83%
5,771 $276,000
Q1 2021

May 13, 2021

BUY
$46.31 - $62.7 $303,098 - $410,371
6,545 New
6,545 $332,000
Q4 2020

Feb 04, 2021

SELL
$55.51 - $69.94 $381,298 - $480,417
-6,869 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$42.19 - $69.61 $2.7 Million - $4.45 Million
-63,990 Reduced 90.31%
6,869 $462,000
Q2 2020

Jul 20, 2020

BUY
$27.55 - $43.28 $991,276 - $1.56 Million
35,981 Added 103.16%
70,859 $2.97 Million
Q1 2020

Apr 30, 2020

BUY
$23.16 - $47.8 $807,774 - $1.67 Million
34,878 New
34,878 $1.1 Million
Q4 2019

Jan 28, 2020

SELL
$27.97 - $40.38 $716,731 - $1.03 Million
-25,625 Closed
0 $0
Q3 2019

Nov 04, 2019

BUY
$31.65 - $46.94 $811,031 - $1.2 Million
25,625 New
25,625 $834,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.